methylene blue has been researched along with mkt 077 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ihara, M; Inoue, H; Kim, HS; Shishido, T; Suzuki, M; Takasu, K; Wataya, Y | 1 |
| Kumar, R; Pavlov, PF; Wang, L; Winblad, B | 1 |
1 review(s) available for methylene blue and mkt 077
| Article | Year |
|---|---|
Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance.
Topics: Alzheimer Disease; Animals; Benzodioxoles; Cholinesterase Inhibitors; Cholinesterases; Curcumin; Humans; Molecular Targeted Therapy; Neurofibrillary Tangles; Neuroprotective Agents; Phosphorylation; Plaque, Amyloid; Protein Aggregation, Pathological; Protein Processing, Post-Translational; Quinazolines; Receptors, N-Methyl-D-Aspartate; tau Proteins; Thiadiazoles | 2021 |
1 other study(ies) available for methylene blue and mkt 077
| Article | Year |
|---|---|
Rhodacyanine dyes as antimalarials. 1. Preliminary evaluation of their activity and toxicity.
Topics: Animals; Antimalarials; Coloring Agents; Plasmodium falciparum; Pyridines; Structure-Activity Relationship; Thiazoles | 2002 |